Cargando…
Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications
The pharmaceutical industry has entered an era of transformation with the emergence of Pharma 4.0, which leverages cutting-edge technologies in manufacturing processes. These hold tremendous potential for enhancing the overall efficiency, safety, and quality of non-biological complex drugs (NBCDs),...
Autores principales: | Malheiro, Vera, Duarte, Joana, Veiga, Francisco, Mascarenhas-Melo, Filipa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674941/ https://www.ncbi.nlm.nih.gov/pubmed/38004525 http://dx.doi.org/10.3390/pharmaceutics15112545 |
Ejemplares similares
-
Pharma 4.0 Continuous mRNA Drug Products Manufacturing †
por: Ouranidis, Andreas, et al.
Publicado: (2021) -
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
por: Ouranidis, Andreas, et al.
Publicado: (2021) -
Pharma 4.0-Artificially Intelligent Digital Twins for Solidified Nanosuspensions
por: Davidopoulou, Christina, et al.
Publicado: (2022) -
Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia
por: Nurlaela Arief, N., et al.
Publicado: (2022) -
From Science 2.0 to Pharma 3.0
por: Basset, Hervé
Publicado: (2012)